Article(id=1329837472290287801, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329837471875051704, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.03.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1677600000000, receivedDateStr=2023-03-01, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794987560578, onlineDateStr=2026-11-18, pubDate=1710000000000, pubDateStr=2024-03-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794987560578, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794987560578, creator=13701087609, updateTime=1794987560578, updator=13701087609, issue=Issue{id=1329837471875051704, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='3', pageStart='233', pageEnd='344', issueExtLink='null', onlineDate='null', pubDate='1710000000000', pubDateStr='2024-03-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794987560480, creator='13701087609', updateTime=1794988245359, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329840345090732938, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329837471875051704, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329840345090732939, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329837471875051704, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=233, endPage=238, ext={EN=ArticleExt(id=1329837472500003002, articleId=1329837472290287801, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Promoting China's model of innovative drug pricing rules, columnId=1326652874119033612, journalTitle=World Clinical Drug, columnName=Recommendation, runingTitle=null, highlight=null, articleAbstract=
Objective

To introduce the contents, significance of the policy on ''Notice on Establishing Initial Launching Market Price Formation for Newly Original Chemicals and Encouraging High-Quality Innovation'' issued by the China Healthcare Security Administration in 2024 and put forward suggestions for improvement.

Methods

The contents and requirements of economic analysis of new drugs with high, middle and low innovative degrees were summarized through policies analysis and literature review, the classification of added benefits of innovative drugs in America, Germany, France and Canada was compared.

Results

Great progress has been made in the research and development of innovative drugs in China in recent years. We should adhere to the basic principle that drug prices should be determined by the market, and give full play to the role of the government in supporting and guiding the prices of newly listed drugs. The innovation degree of new drugs is evaluated from three dimensions: pharmaceutical basis, clinical value and evidence-based information. The evaluation system consists of 3 first-grade indexes, 13 second-grade indexes and 34 third-grade indexes, which are classified into high (90 — 150 scores), middle (50 — 90 scores) and low (below 50 scores) categories according to the scores value, to guide pharmaceutical companies to self-evaluating the innovation degree of newly listed chemicals.

Conclusion

The new policy encourages the development of high-quality innovative drugs, and takes the clinical value as the priority, paying attention on the added therapeutic benefit assessment. The new policy clarifies the composition of the ''basket'' and ''initial price'' of countries and regions of external reference pricing that has been established in China. The composition including 5 parts, the manufacturing costs, production period costs, sales profits, taxes, and distributor/wholesaler's mark-up. It should fully mobilize the initiative of free-pricing system by the pharmaceutical enterprises, recommendation from trade associations, clinical professional opinions issued by medical institutions, mobilize the enthusiasm of health technology assessment agencies and multi-disciplinary experts, finally conduct the social co-governance of drug prices in China.

, authors=Shanlian HU, authorsList=Shanlian HU, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329837472835547323, articleId=1329837472290287801, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=开启中国模式的创新药物定价规则, columnId=1326652874295194382, journalTitle=世界临床药物, columnName=本期推荐, runingTitle=null, highlight=null, articleAbstract=
目的

介绍2024年中国医疗保障局发布的《关于建立新上市化学药品首发价格形成机制鼓励高质量创新的通知》政策内容、意义,并提出完善建议。

方法

通过政策和文献分析,总结高、中、低3类不同创新程度的新药经济性分析的内容和要求,并对美国、德国、法国及加拿大对创新药附加效益的分类进行比较。

结果

近年来中国创新药的研发获得很大进展。坚持药品价格由市场决定的基本原则,发挥政府对新上市药品价格的支持和指引作用。现提出从药学基础、临床价值及循证证据3个维度评价新药的创新程度。评价体系包含3个一级指标、13个二级指标及34个三级指标,按分值进入高(90~150分)、中(50~90分)及低(50分以下)3个组别,引导药企自我测评新上市化学药品的创新程度。

结论

新政策鼓励高质量创新药物的发展,以临床价值为导向,重视新药的附加治疗效益,明确中国建立境外参考价格的国家和地区的“篮子”和“首发价格”的构成,包括生产制造成本、期间费用、销售利润、税费及流通环节差价5个部分。充分调动药企自主评价、行业协会推荐书、医疗机构出具临床专业意见书,以及调动卫生技术评估专业评价机构、多学科专家的积极性,对药品价格进行社会共治。

, authors=胡善联, authorsList=胡善联, authorCompany=null, correspAuthors=null, authorNote=

胡善联,教授,博士生导师,研究方向:卫生经济学。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=G56jBTwaLoTaBQrqu2Taeg==, magXml=LnHjr8nj2JvJyUEhuozlWQ==, pdfUrl=null, pdf=QFBb4seKmwhcrGwh92W8Lg==, pdfFileSize=1896518, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=gtN1zTy28EFHrTjLyAKMBQ==, mapNumber=null, fund=null)}, authors=[Author(id=1329837473095594176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329837473171091650, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, authorId=1329837473095594176, language=EN, stringName=Shanlian HU, firstName=Shanlian, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Health Economics, School of Public Health, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329837473238200515, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, authorId=1329837473095594176, language=CN, stringName=胡善联, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学公共卫生学院卫生经济学教研室,上海 200032, bio={"content":"

胡善联,教授,博士生导师,研究方向:卫生经济学。

"}, bioImg=null, bioContent=

胡善联,教授,博士生导师,研究方向:卫生经济学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329837473007513788, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, xref=null, ext=[AuthorCompanyExt(id=1329837473015902397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, companyId=1329837473007513788, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Health Economics, School of Public Health, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329837473028485310, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, companyId=1329837473007513788, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学公共卫生学院卫生经济学教研室,上海 200032)])])], keywords=[Keyword(id=1329837473330475204, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, language=EN, orderNo=1, keyword=chemical), Keyword(id=1329837473397584069, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, language=EN, orderNo=2, keyword=launching market price), Keyword(id=1329837473473081542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, language=EN, orderNo=3, keyword=high-quality development), Keyword(id=1329837473535996103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, language=EN, orderNo=4, keyword=market mechanism), Keyword(id=1329837473594716360, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, language=EN, orderNo=5, keyword=independent pricing), Keyword(id=1329837473657630921, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, language=CN, orderNo=1, keyword=化学药品), Keyword(id=1329837473707962570, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, language=CN, orderNo=2, keyword=上市价格), Keyword(id=1329837473766682827, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, language=CN, orderNo=3, keyword=高质量发展), Keyword(id=1329837473842180300, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, language=CN, orderNo=4, keyword=市场机制), Keyword(id=1329837473934454989, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, language=CN, orderNo=5, keyword=自主定价)], refs=[Reference(id=1329837474039312591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=武星如. 新药进医保“提速”, 患者等待时间从5年缩短至2年[EB/OL]. (2024-03-01) [2024-03-01]. https://m.baidu.com/bh/m/detail/ar_9591607006489434933., articleTitle=null, refAbstract=null), Reference(id=1329837474110615760, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=DiStefano MJ, Kang SY, Yehia F, et al. Assessing the added therapeutic benefit of ultra-expensive drugs[J]. Value Health, 2021, 24(3): 397-403., articleTitle=null, refAbstract=null), Reference(id=1329837474186113233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Anderson KE, DiStefano MJ, Liu A, et al. Incorporating added therapeutic benefit and domestic reference pricing into medicare payment for expensive part B drugs[J]. Value Health, 2023, 26(9): 1381-1388., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329837473007513788, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, xref=null, ext=[AuthorCompanyExt(id=1329837473015902397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, companyId=1329837473007513788, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Health Economics, School of Public Health, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329837473028485310, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, companyId=1329837473007513788, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学公共卫生学院卫生经济学教研室,上海 200032)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.03.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.03.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.03.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.03.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1710000000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
开启中国模式的创新药物定价规则
胡善联
世界临床药物 | 本期推荐 2024,45(3): 233-238
收起
收藏切换
世界临床药物 |本期推荐 2024 , 45 (3) : 233 -238
开启中国模式的创新药物定价规则
全屏
[Author(id=1329837473095594176, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329837473171091650, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, authorId=1329837473095594176, language=EN, stringName=Shanlian HU, firstName=Shanlian, middleName=null, lastName=HU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Health Economics, School of Public Health, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329837473238200515, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, authorId=1329837473095594176, language=CN, stringName=胡善联, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=复旦大学公共卫生学院卫生经济学教研室,上海 200032, bio={"content":"

胡善联,教授,博士生导师,研究方向:卫生经济学。

"}, bioImg=null, bioContent=

胡善联,教授,博士生导师,研究方向:卫生经济学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329837473007513788, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, xref=null, ext=[AuthorCompanyExt(id=1329837473015902397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, companyId=1329837473007513788, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Health Economics, School of Public Health, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329837473028485310, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329837472290287801, companyId=1329837473007513788, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=复旦大学公共卫生学院卫生经济学教研室,上海 200032)])])]
胡善联
作者信息
  • 复旦大学公共卫生学院卫生经济学教研室,上海 200032
作者简介:

胡善联,教授,博士生导师,研究方向:卫生经济学。

Promoting China's model of innovative drug pricing rules
Shanlian HU
Affiliations
  • Department of Health Economics, School of Public Health, Fudan University, Shanghai 200032, China
出版时间: 2024-03-10 doi: 10.13683/j.wph.2024.03.001
文章导航
收藏切换
目的

介绍2024年中国医疗保障局发布的《关于建立新上市化学药品首发价格形成机制鼓励高质量创新的通知》政策内容、意义,并提出完善建议。

方法

通过政策和文献分析,总结高、中、低3类不同创新程度的新药经济性分析的内容和要求,并对美国、德国、法国及加拿大对创新药附加效益的分类进行比较。

结果

近年来中国创新药的研发获得很大进展。坚持药品价格由市场决定的基本原则,发挥政府对新上市药品价格的支持和指引作用。现提出从药学基础、临床价值及循证证据3个维度评价新药的创新程度。评价体系包含3个一级指标、13个二级指标及34个三级指标,按分值进入高(90~150分)、中(50~90分)及低(50分以下)3个组别,引导药企自我测评新上市化学药品的创新程度。

结论

新政策鼓励高质量创新药物的发展,以临床价值为导向,重视新药的附加治疗效益,明确中国建立境外参考价格的国家和地区的“篮子”和“首发价格”的构成,包括生产制造成本、期间费用、销售利润、税费及流通环节差价5个部分。充分调动药企自主评价、行业协会推荐书、医疗机构出具临床专业意见书,以及调动卫生技术评估专业评价机构、多学科专家的积极性,对药品价格进行社会共治。

化学药品  /  上市价格  /  高质量发展  /  市场机制  /  自主定价
Objective

To introduce the contents, significance of the policy on ''Notice on Establishing Initial Launching Market Price Formation for Newly Original Chemicals and Encouraging High-Quality Innovation'' issued by the China Healthcare Security Administration in 2024 and put forward suggestions for improvement.

Methods

The contents and requirements of economic analysis of new drugs with high, middle and low innovative degrees were summarized through policies analysis and literature review, the classification of added benefits of innovative drugs in America, Germany, France and Canada was compared.

Results

Great progress has been made in the research and development of innovative drugs in China in recent years. We should adhere to the basic principle that drug prices should be determined by the market, and give full play to the role of the government in supporting and guiding the prices of newly listed drugs. The innovation degree of new drugs is evaluated from three dimensions: pharmaceutical basis, clinical value and evidence-based information. The evaluation system consists of 3 first-grade indexes, 13 second-grade indexes and 34 third-grade indexes, which are classified into high (90 — 150 scores), middle (50 — 90 scores) and low (below 50 scores) categories according to the scores value, to guide pharmaceutical companies to self-evaluating the innovation degree of newly listed chemicals.

Conclusion

The new policy encourages the development of high-quality innovative drugs, and takes the clinical value as the priority, paying attention on the added therapeutic benefit assessment. The new policy clarifies the composition of the ''basket'' and ''initial price'' of countries and regions of external reference pricing that has been established in China. The composition including 5 parts, the manufacturing costs, production period costs, sales profits, taxes, and distributor/wholesaler's mark-up. It should fully mobilize the initiative of free-pricing system by the pharmaceutical enterprises, recommendation from trade associations, clinical professional opinions issued by medical institutions, mobilize the enthusiasm of health technology assessment agencies and multi-disciplinary experts, finally conduct the social co-governance of drug prices in China.

chemical  /  launching market price  /  high-quality development  /  market mechanism  /  independent pricing
胡善联. 开启中国模式的创新药物定价规则. 世界临床药物, 2024 , 45 (3) : 233 -238 . DOI: 10.13683/j.wph.2024.03.001
Shanlian HU. Promoting China's model of innovative drug pricing rules[J]. World Clinical Drug, 2024 , 45 (3) : 233 -238 . DOI: 10.13683/j.wph.2024.03.001

参考文献 引证文献
排序方式:
[1]
武星如. 新药进医保“提速”, 患者等待时间从5年缩短至2年[EB/OL]. (2024-03-01) [2024-03-01]. https://m.baidu.com/bh/m/detail/ar_9591607006489434933.
[2]
DiStefano MJ, Kang SY, Yehia F, et al. Assessing the added therapeutic benefit of ultra-expensive drugs[J]. Value Health, 2021, 24(3): 397-403.
[3]
Anderson KE, DiStefano MJ, Liu A, et al. Incorporating added therapeutic benefit and domestic reference pricing into medicare payment for expensive part B drugs[J]. Value Health, 2023, 26(9): 1381-1388.
2024年第45卷第3期
11
2
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.03.001
  • 接收时间:2023-03-01
  • 首发时间:2026-11-18
  • 出版时间:2024-03-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-03-01
基金
作者信息
    复旦大学公共卫生学院卫生经济学教研室,上海 200032
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.03.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏